Daily News Podcast

Bempedoic acid: funny name, serious LDL lowering

Publish date: March 15, 2019

 

Bempedoic acid safely dropped LDL cholesterol, and now it’s up for FDA approval. Recent trials advance axial spondyloarthritis therapy. Newer antihyperglycemic drugs have distinctive cardiovascular, kidney benefits. And doctors’ prior authorization burden is increasing.
Amazon Alexa
Apple Podcasts
Google Podcasts
Spotify

Recommended Reading

A prescription for medicine’s gender inequality
MDedge Endocrinology
Parental leave inequities: Kirti Magudia and Thomas Ng, Part I
MDedge Endocrinology
Trump targets abortion by denying family planning funds
MDedge Endocrinology
Will having fewer primary care physicians shorten Americans’ lifespans?
MDedge Endocrinology
Cancer-battling breath, Zombie Bambi, and hops as health food
MDedge Endocrinology
Esketamine gets the green light for depression
MDedge Endocrinology
Ready for universal hepatitis C testing?
MDedge Endocrinology
Autism risk with in utero infections
MDedge Endocrinology
Aspirin and lower risk of COPD flare-up
MDedge Endocrinology
Semaglutide plus SGLT2 inhibitors for type 2 diabetes
MDedge Endocrinology